Study claims that 550 million people in India have
vision problems
Nearly 550 million people – almost half of India’s
population – have vision problems, and so doctors must be trained in latest
techniques for correcting vision problems, an official said on Thursday.
Mahipal Sachdev, chairman-scientific committee, Intra Ocular Implant and
Refractive Society of India (IIRSI) and chairman of Centre for Sight group of
eye hospitals (CFS), said Ophthalmology is an ever-evolving field and that
doctors need to keep themselves up to date.
‘In India, as many as 550 million people – almost half of
India’s population – are estimated to be suffering from vision problems and
correction. Therefore, it is important that doctors adopt latest vision
correction techniques like replacing of cloudy lens in the case of cataract –
the most common eye problem in people above 60 years of age – with Intra Ocular
Lens (IOL) using blade-free femtosecond laser technology,’ said Sachdev.
He said that ‘femtosecond laser technique is the most
advanced technology for correction of cataract and refractive errors’. The
IIRSI in collaboration with CFS will organise a two-day conference here in the
national capital from Friday to discuss eye treatment in hospitals. Ritika
Sachdev, additional director-clinical cervices, CFS, said: ‘People wanting to
get rid of eyeglasses can immensely benefit from the technology without having
to experience any side-effect or discomfort.’
03.10.2015
Study finds insulin pumps to be
safe for up to five years
Insulin pumps are safe for up to five years in patients
with type 2 diabetes and could be a useful option for those who have failed to
control their blood glucose levels through insulin injections, according to a
new study. ‘Insulin pumps can act as a valuable new treatment option,
especially for those individuals failing on current injections regimens,’ said
study author Priyamvada Singh, MD, St. Vincent Hospital, Worcester,
Massachusetts. She added that around 30 percent of type
2 diabetes patients who
require insulin injections fail to gain control over their blood glucose levels
through daily multiple injections of basal and bolus insulin. In such cases,
‘insulin pumps can act as a valuable new treatment option.’
The study involved only 13 participants, but it was the
longest ever trial concerning insulin pumps and type 2 diabetes, diabetes.co.uk
reported on Wednesday. A lack of long-term data has led to a reluctance to
provide insulin pump therapy to people with type 2 diabetes. ‘This patient
population [had been] very frustrated because they had tried everything…Most of
them were very happy,’ Singh said. All participants in the study had HbA1c
levels higher than seven percent and all were on either an insulin regimen or
insulin plus metformin. After five years, the average HbA1c level had dropped
from 8.9 percent to 7.7 percent. One participant’s HbA1c dropped from 10.5
percent to 6.6 percent. There was a small amount of weight gain and three
participants experienced mild episodes of hypoglycemia. According to Singh,
much larger studies are needed to confirm the findings, which were presented on
September 17 at the European Association for the Study of Diabetes (EASD) 2015
Meeting in Stockholm, Sweden
03.10.2015
An error does not become truth by reason of
multiplied propagation, nor does truth become error because nobody sees it
Mahatma Gandhi
No comments:
Post a Comment